Orthogonal Thinker

Orthogonal Thinker, a platform company focused on the use of whole plant products and psychoactive compounds for health and wellbeing, announced Monday the close of an oversubscribed seed funding round of $6 million. The company was valued at $111 million, and received investments from Republic...

Psyched is a bi-monthly column covering the most important developments in the industry of medicinal psychedelics. We hope you follow us periodically as we report on the growth of this exciting new industry. ATAI Life Sciences Announces Closing Of $24M Convertible Round  On Thursday, biotech...

Biotechnology company Orthogonal Thinker has filed an application for a proprietary psilocybin product with the United States Patent and Trademark Office (USPTO). The Kihei, Hawaii-based company, which is focused on whole plant products as well as psychoactive compounds, has...